NRXP News and Press, NRX Pharmaceuticals Inc. From 05/08/24

2024-05-08 09:07:02 ET Michigan, United States, April 29th, 2024, FinanceWire NRx Pharmaceuticals, Inc. (Nasdaq: NRXP ) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, spe...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024 PR Newswire RADNOR, Pa. , May 8, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical...

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024 PR Newswire RADNOR, Pa. , May 7, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharm...

A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 8.1% to $25.21 on volume of 141,121,870 shares Lyra Therapeutics Inc. (LYRA) fell 87.1% to $0.5215 on volume of 107,579,343 shares PROSHARES TRUST (SQQQ) fell 3.4% to $10.7 on volume of 9...

2024-05-06 13:17:53 ET More on Mid-day movers & stocks. Manitex International, Inc. 2024 Q1 - Results - Earnings Call Presentation Manitex International, Inc. (MNTX) Q1 2024 Earnings Call Transcript Manitex International, Inc. (MNTX) Q4 2023 Earnings Call Transcr...

2024-05-06 10:01:41 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...

A look at the top 10 most actives in the United States XBP Europe Holdings Inc. (XBP) rose 69.1% to $3.5846 on volume of 37,660,870 shares Lyra Therapeutics Inc. (LYRA) fell 90.2% to $0.3942 on volume of 21,985,500 shares NIO Inc. American depositary shares each representing one Class A (...

2024-05-06 08:52:01 ET More on NRx Pharmaceuticals NRX Pharmaceuticals, Inc. (NRXP) Q4 2023 Earnings Call Transcript NRx Pharmaceuticals regains compliance with Nasdaq minimum bid price requirement NRx Pharmaceuticals announces proposed underwritten public offering o...

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression PR Newswire Both drugs demonstrated > 50% response for treating depression....

2024-05-01 10:00:09 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 19 out...